Adults 15 to 17, any sex, with Autism Spectrum Disorder or Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Transition Readiness Assessment Questionnaire (TRAQ) ChangePrimary· Baseline and 6-Month Visit
While Transition Readiness Assessment Questionnaire (TRAQ) measure refinement is ongoing, and other versions are now available, our sample size calculation is based on findings from an intervention trial where the 29-item version of the TRAQ was used. The 29-item version has a Self-management domain score (16 items) and a Self-advocacy domain score (13 items). Both the TRAQ Self-management and TRAQ Self-advocacy domain scores are reported. Scores range from 1 to 5. Higher scores mean better transition readiness.
Self-management Baseline Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
2.3
± 0.6
Control Group: Usual Care
2.2
± 0.5
Self-management 6-Month Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
2.5
± 0.7
Control Group: Usual Care
2.5
± 0.9
Self-advocacy Baseline visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
3.4
± 0.6
Control Group: Usual Care
3.0
± 0.5
Self-advocacy 6-Month Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
3.6
± 0.6
Control Group: Usual Care
3.2
± 0.8
Canadian Occupational Performance Measure (COPM) ChangeSecondary· Baseline and 6-Month Visit
The Canadian Occupational Performance Measure (COPM) is an evidence-based, generic, and individualized outcome measure used to capture a client's self-perception of performance and satisfaction in everyday living over time, by identifying problems in performing activities of daily living. Participants are encouraged to think about things (goals) that they want to do, need to do or are expected to do but can't do, don't do or aren't satisfied with the way they do. Participants are asked to rate current performance using a 10-point scale ranging from 1'not able to do it' to 10 'able to do it ver
Performance Baseline Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
4.3
± 1.8
Control Group: Usual Care
5.3
± 2.2
Performance 6-Month Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
6.0
± 1.6
Control Group: Usual Care
6.7
± 2.3
Satisfaction Baseline Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
4.8
± 2.1
Control Group: Usual Care
5.2
± 2.2
Satisfaction 6-Month Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
6.3
± 1.9
Control Group: Usual Care
7.3
± 2.3
TRANSITION-Q ChangeSecondary· Baseline and 6-Month Visit
The TRANSITION-Q is a 14-item transition readiness/self-management ability scale. This short, clinically meaningful and psychometrically sound scale can be used in research and in pediatric and adolescent clinics to help evaluate readiness for transition to adult care. Item responses ("never" = 0, "sometimes" = 1, and "always" = 2) are summed to create a raw score, with a possible range from 0 to 28. Raw scores are transformed using a table provided by the developers and the transformed scores range from 0-100. A higher score indicates greater transition readiness; exhibiting more self-managem
Baseline Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
57.0
± 10.1
Control Group: Usual Care
56.1
± 10.4
6-Month Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
59.4
± 13.2
Control Group: Usual Care
52.2
± 19.6
Pediatric Quality of Life Instrument (PedsQL[TM]) ChangeSecondary· Baseline and 6-Month Visit
The Pediatric Quality of Life Instrument (PedsQL\[TM\]) takes a modular approach to measuring health-related quality of life (HRQOL) in healthy children and adolescents and those with acute and chronic health conditions. In this study the PedsQL\[TM\] Pediatric Quality of Life Instrument, Generic Core, Teen Report (13-18 years) was completed. The form is brief (23 items), practical (less than 4 minutes to complete), multidimensional (Physical, Emotional, Social, School Functioning), reliable (Child Self-Report; 0.90) and valid (Distinguishes between healthy children and children with acute and
Baseline Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
64.5
± 16.5
Control Group: Usual Care
64.6
± 20.8
6 Month Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
63.2
± 18.3
Control Group: Usual Care
66.2
± 18.1
Measure of Process of Care (MPOC) ChangeSecondary· Baseline and 6-Month Visit
The Measure of Processes of Care (MPOC) is a well-validated and reliable self-report measure of parents' perceptions of the extent to which the health services they and their children receive are family-centred. The original version of MPOC is a 56-item questionnaire; as of 1999 there is a shorter, 20-item version called MPOC-20 which was used (and modified with permission) in this study. Five MPOC-20 scale scores are reported: Enabling and Partnership, Providing General Information, Providing Specific Information, Coordination and Comprehensive Care, Respectful and Supportive Care. A 7-point
Enabling and Partnership Baseline Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
4.6
± 1.5
Control Group: Usual Care
4.3
± 1.6
Enabling and Partnership 6-Month Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
4.5
± 1.8
Control Group: Usual Care
4.4
± 1.7
Providing General information Baseline Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
3.4
± 1.6
Control Group: Usual Care
3.6
± 1.7
Providing General information 6 Month Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
3.3
± 1.7
Control Group: Usual Care
3.6
± 1.8
Providing Specific information Baseline Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
4.2
± 1.5
Control Group: Usual Care
4.3
± 1.4
Providing Specific information 6-Month Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
4.2
± 2.1
Control Group: Usual Care
4.4
± 1.6
Coordination and comprehensive care Baseline Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
4.8
± 1.5
Control Group: Usual Care
4.7
± 1.3
Coordination and comprehensive care 6-Month Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
4.6
± 2.0
Control Group: Usual Care
4.7
± 1.6
Health Utilities Index® (Hui2/3) Proxy-Assessed ChangeSecondary· Baseline and 6-Month Visit
The HUI is a generic health status instrument developed in Canada for use with children and has been incorporated in numerous clinical studies as well as the Canadian Community Health Survey, allowing the generation of norms for most age groups. The HUI Mark II includes 7 attributes: Sensation, Mobility, Emotion, Cognition, Self-care, Pain and Fertility with each attribute divided into 3 to 5 levels. The HUI III includes 8 attributes: Vision, Hearing, Speech, Ambulation, Dexterity, Emotion, Cognition and Pain. Each attribute of the HUI III consists of 5 to 6 levels. We report the overall healt
Baseline Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
3.9
± 0.9
Control Group: Usual Care
4.1
± 1.0
6-Month Visit
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
4.0
± 0.8
Control Group: Usual Care
4.0
± 0.7
Resource Use Questionnaire (RUQ) ChangeSecondary· 6-Month Visit
The RUQ is typically an interviewer-administered questionnaire for parents of children aged 11 to 18 years. The original RUQ measures the family resource use of condition-related treatments, services and programs, as well as parent time losses and family out-of-pocket costs. It also documents condition-related government subsidies and funding that families receive. Resources measured include those delivered by a parent, by other providers (e.g. behavioural specialist) or a combination of both. In this project, we will use a modified subset of RUQ questions, self-completed by the parent/caregiv
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
2
Control Group: Usual Care
3
System Usability Scale (SUS)Secondary· 6-Month Visit
The SUS will be administered to youth in the Experimental Arm. The measure focus is on users' utilization of the application and its features, the perceived value and their experience and satisfaction with the intervention. The self-reported survey will provide additional information about the users' adherence, behavior, motivation and experience with the IT platform, as well as about the main reasons for using or not using it. Measures youth's subjective perceptions of the usability of the App, scored from 0 - 100 with a higher score indicating greater usability.
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
65.4
± 26.8
Utilization of Intervention (Usage, Adherence, and Fidelity)Secondary· 6-Month Visit
Mixed methods will be used to assess MyREADY Transition\[TM\] BBD App usage, adherence and fidelity, and to identify the barriers and facilitators to using the e-health application for users. Quantitative data will be collected through participant self-report and by the app daily through study completion. For a subset of participants in the intervention group, qualitative data will be collected via interview. Utilization of Intervention reporting at 6-Month Visit.
Usage reported here as the average number of times intervention participants logged into the App.
Group
Value
95% CI
Usual Care + MyREADYTransition[TM] BBD App
11.2
± 9.5
Sponsor's own description
The purpose of this study is to find out if there is a benefit to using the MyREADY Transition\[TM\] BBD App for brain-based disabilities, compared to not using it. To do this, some of the participants in this study will use the MyREADY Transition\[TM\] BBD App and others will not use the App. Everyone will continue to get the same care they have been getting (their usual care).
The study team wants to see how youth will use the MyREADY Transition\[TM\] BBD App as they are getting ready to leave the children's hospital or children's treatment centre. And, they want to see if it will help youth to be knowledgeable about their own health. The study team hopes to see youth taking steps to develop the skills so they become better managers of their health. For example, this would include knowing about their medication or knowing when to ask for help from parents/caregivers and health care providers.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
NCT06235476 — Protein Intake and Exercise-induced Muscle Damage
· NA
· completed
Other recruiting trials for Autism Spectrum Disorder
Currently open trials in the same condition.
NCT07324057 — The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi
· NA
· recruiting
NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor
· recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f
· NA
· active not recruiting
NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre
· NA
· recruiting
NCT07432776 — Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
· EARLY_PHASE1
· recruiting
Other McMaster University trials
Trials by the same sponsor.
NCT06231069 — Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults
· NA
· withdrawn
NCT07213492 — Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder
· NA
· recruiting
NCT07486505 — Mindfulness in Fracture Recovery and Reduction of Opioid Reliance: Evaluating the Feasibility of Implementing a Brief, M
· NA
· not yet recruiting
NCT07459777 — Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anteri
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by McMaster University
Last refreshed: 21 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03852550.